P3 Health Partners (PIII) CFO awarded 30,000 stock options at $3.5479

Rhea-AI Filing Summary

P3 Health Partners Inc. reported that its Chief Financial Officer, Leif Elliott Pedersen, received a grant of stock options covering 30,000 shares of Class A common stock. The options have an exercise price of $3.5479 per share, become exercisable on May 8, 2030, and expire on May 8, 2036. Following this award, Pedersen holds stock options for a total of 45,000 shares, reflecting a routine compensation-related equity grant rather than an open-market purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Pedersen Leif Elliott

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	30,000	$3.5479	$106K

Holdings After Transaction: Stock Option (Right to Buy) — 45,000 shares (Direct, null)

Footnotes (1)

Key Figures

Option grant size: 30,000 options Exercise price: $3.5479 per share Underlying shares: 30,000 shares +3 more

6 metrics

Option grant size 30,000 options Stock Option (Right to Buy) granted to CFO on May 8, 2026

Exercise price $3.5479 per share Conversion or exercise price of granted stock options

Underlying shares 30,000 shares Class A common stock underlying the stock options

Post-grant option holdings 45,000 options Total stock options held by CFO after this transaction

Exercise start date May 8, 2030 Date when the options become exercisable

Expiration date May 8, 2036 Date when the stock options expire

Key Terms

Stock Option (Right to Buy), exercise price, expiration date, grant, award, or other acquisition, +1 more

5 terms

Stock Option (Right to Buy) financial

"security_title: Stock Option (Right to Buy)"

exercise price financial

"conversion_or_exercise_price: 3.5479"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: 2036-05-08T00:00:00.000Z"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Class A Common Stock financial

"underlying_security_title: Class A Common Stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pedersen Leif Elliott

(Last) (First) (Middle)

C/O P3 HEALTH PARTNERS INC.

2370 CORPORATE CIRCLE, SUITE 300

(Street)

HENDERSON NEVADA 89074

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
P3 Health Partners Inc. [ PIII ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$3.5479	05/08/2026		A		30,000		05/08/2030	05/08/2036	Class A Common Stock	30,000	$3.5479	45,000	D

Explanation of Responses:

Remarks:

	/s/ Todd Smith, as attorney-in-fact	05/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did P3 Health Partners (PIII) disclose about its CFO in this Form 4?

P3 Health Partners disclosed that Chief Financial Officer Leif Elliott Pedersen received a grant of stock options for 30,000 shares of Class A common stock as compensation, increasing his total stock option holdings to 45,000 shares following this award.

What is the exercise price of the CFO stock options at P3 Health Partners (PIII)?

The granted stock options have an exercise price of $3.5479 per share. This means the CFO can buy P3 Health Partners’ Class A common stock at $3.5479 per share once the options become exercisable, regardless of the market price at that time.

When do the new CFO stock options at P3 Health Partners (PIII) vest and expire?

The stock options granted to the CFO become exercisable on May 8, 2030, and expire on May 8, 2036. This provides a six-year exercise window after vesting, aligning the award with longer-term company performance and executive retention.

How many P3 Health Partners (PIII) stock options does the CFO hold after this grant?

After the reported grant, the CFO holds stock options for 45,000 shares of Class A common stock. The Form 4 indicates that 30,000 options were newly awarded, bringing his total derivative holdings to 45,000 options directly owned.

Is the P3 Health Partners (PIII) CFO Form 4 an open-market stock purchase or sale?

No, the Form 4 reflects a compensation-related stock option grant, not an open-market trade. The transaction is coded as a grant or award acquisition (code A), meaning the company awarded options rather than the CFO buying or selling shares in the market.